Paul I. Parren
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'.
Journal: Annals of the rheumatic diseases
Published: November 13, 2025
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation.
Journal: Journal of autoimmunity
Published: January 17, 2025
Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigens.
Journal: Annals of the rheumatic diseases
Published: December 30, 2024
The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients.
Journal: Frontiers in immunology
Published: December 21, 2024
Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.
Journal: Nature biomedical engineering
Published: March 26, 2024
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 04, 2023
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators.
Journal: Frontiers in immunology
Published: September 04, 2023
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells.
Journal: Frontiers in immunology
Published: March 10, 2023
Last Updated: 09/26/2026